Kaitlyn Melanie Arsenault
Chief Financial Officer, Skye Bioscience, Inc.
Companies
- Skye Bioscience, Inc.Chief financial officer Oct 5, 2021 to Apr 28, 20261
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Skye Bioscience, Inc. SKYE167,522 shares2$256.3K at $1.53Nov 18, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Nov 18, 2024Sold 43,206 shares at $4.99 of Skye Bioscience, Inc.3
- Nov 18, 2024Sold 43,026 shares at $4.99 of Skye Bioscience, Inc.2
- Nov 15, 2024Sold 190 shares at $5.55 of Skye Bioscience, Inc.3
- Nov 15, 2024Sold 190 shares at $5.55 of Skye Bioscience, Inc.2
- Feb 29, 2024Granted 25,000 shares of Skye Bioscience, Inc.4
- Feb 29, 2024Granted 25,000 shares of Skye Bioscience, Inc.5
- Nov 6, 2023Granted 128,209 shares of Skye Bioscience, Inc.6
- Aug 25, 2023Granted 13,382,118 shares of Skye Bioscience, Inc.7
- Dec 14, 2021Granted 1,000,000 shares of Skye Bioscience, Inc.8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Nov 19, 2024
- 4SEC EDGARForm 4 filed Mar 4, 2024
- 5SEC EDGARForm 4 filed Mar 1, 2024
- 6SEC EDGARForm 4 filed Nov 6, 2023
- 7SEC EDGARForm 4 filed Aug 29, 2023
- 8SEC EDGARForm 4 filed Dec 16, 2021